ACCELERA INNOVATIONS, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-11-29: Form 8-K; Period of report 2017-11-28; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2017-10-04: Form 8-K; Period of report 2017-10-04; Description 8.01 Other Events; Details 8.01.
- 2017-04-24: Form 8-K; Period of report 2017-04-24; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2017-04-03: Form 8-K; Period of report 2017-04-03; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-11-29 | 8-K | 2017-11-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Cynthia Boerum, current Chief Strategic Officer and interim COO of Accelera Innovations, Inc, has submitted her resignation on November 28, 2017. | form8-k.htm |
| 2017-10-04 | 8-K | 2017-10-04 | 8.01 Other Events | 8.01 On September 29, 2017, Accelera Innovations, Inc. (the “Company”) received a SEC lawsuit against Accelera Innovations Inc., Synergistic Holdings LLC and Geoffrey Thompson; Jury Trial Demanded Civil Action No: 1:17-cv-7052. | form8k.htm |
| 2017-04-24 | 8-K | 2017-04-24 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 John Wallin, acting CEO and CFO of Accelera Innovations Inc. has submitted his retirement on April 20, 2017. | form8-k.htm |
| 2017-04-03 | 8-K | 2017-04-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 1, 2017, James Millikan retired as the Chief Operating Officer of Accelera Innovations, Inc. (the Company). | form8-k.htm |
| 2016-11-17 | 8-K | 2016-11-15 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On November 15, 2016 Accelera Innovations, Inc. (the “Company”) notified Anton & Chia LLP (“Anton”), the Company’s independent registered public accounting firm, that the Company engaged a new independent registered public accounting firm and thereby was terminating its relationship with Anton. | form8-k.htm |
| 2016-04-06 | 8-K | 2016-03-31 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 In conjunction with the Termination Agreement, Dr. Wolfrum resigned as the President of Accelera Healthcare. | form8-k.htm |
| 2016-02-11 | 8-K | 2016-02-04 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2015-08-27 | 8-K | 2015-08-21 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2015-07-21 | 8-K | 2015-07-20 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | 4.02 On July 20, 2015 the Board of Directors of Accelera Innovations, Inc. (the “Company”) determined that the Company’s financial statements included in its Form 10-Q’s for the periods ended March 31, 2013, June 30, 2013 and September 30, 2013 and its Form 10-K for the year ended December 31, 2013, its Form 10-Q’s for the periods ended March 31, 2014, June 30, 2014 and September 30, 2014 and Form 10-K for the year ended December 31, 2014 (collectively, the “Financial Statements”) could not be relied on. | form8-k.htm |
| 2015-07-07 | 8-K | 2015-07-01 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2015-05-13 | 8-K | 2015-05-08 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On May 8, 2015, Accelera Innovations, Inc. (the “Company”) filed a Certificate of Designation, Preferences, and Rights of 8% Convertible Preferred Stock (the “Certificate of Designation”) with the State of Delaware to designate 500,000 shares of 8% Convertible Preferred Stock. | form8-k.htm |
| 2015-03-24 | 8-K | 2015-03-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 20, 2015, Daniel Freeman resigned as the Chief Financial Officer of Accelera Innovations, Inc. (“we,” “us,” “our,” or the “Company”). | form8-k.htm |
| 2015-01-09 | 8-K | 2015-01-05 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On January 9, 2015 we issued a press release regarding the execution of the Traditions SPA. | form8-k.htm |
| 2014-12-04 | 8-K | 2014-11-25 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. | form8k.htm |
| 2014-10-22 | 8-K | 2014-10-16 | 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | 2.04 On October 16, 2014 Accelera Innovations, Inc., (“Accelera” or the “Company”) received Notice of Default under the Purchase Agreement executed between Accelera Innovations, Inc. and At Home Health Services, LLC and All Staffing Services, LLC on December 13, 2014 (the “Gallagher Purchase Agreement”); Notice of Default under the Employment Agreement between Accelera Innovations, Inc. and Rose M. Gallagher dated December 13, 2013 (the “Rose M. Gallagher Employment Agreement”); Notice of Default under the Employment Agreement between Accelera Innovations, Inc. and Daniel P. Gallagher dated December 13, 2013 (the “Daniel P. Gallagher Employment Agreement”); and Notice of Default from Rose M. Gallagher as Assignee of Share Interest under the Employment Agreement between Shawn D. Gallagher and At Home Health Management, LLC (collectively, the “Notices of Default”). | form8k.htm |
| 2014-10-14 | 8-K | 2014-08-25 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.01 The information called for by this Item 2.01 is contained in Item 1.01 hereof and incorporated herein by reference. 2.03 The information called for by this Item 2.03 is contained in Item 1.01 hereof and incorporated herein by reference. | form8k.htm |
| 2014-10-08 | 8-K | 2014-10-08 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | accelera8k_1082014.htm | |
| 2013-12-16 | 8-K | 2013-12-13 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On December 13, 2013 Accelera Innovations, Inc. (“Accelera”) entered in to Purchase Agreement and its wholly owned subsidiary, At Home Health Management LLC. 5.02 On December 13, 2013, Accelera entered into a three-year Employment Agreement with Rose M. Gallagher as the President of Accelera’s At Home Health Care business unit reporting to John Wallin, Accelera’s CEO. | acceerla8k12132013.htm |
| 2013-12-02 | 8-K | 2013-12-02 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On November 20, 2013, the Company entered into an employment agreement with Blaise J. Wolfrum, M.D., as the President of the Accelera business unit “Behavioral Health Care Associates” reporting to John Wallin, CEO of Accelera. | accelera8kbhca.htm |
| 2013-10-23 | 8-K | 2013-10-22 | 8.01 Other Events | 8.01 Accelera Innovations, Inc. a Chicago-based healthcare software-as-a-service provider (the “Company”) today announced it has entered into a Standby Equity Purchase Agreement (“Investment Agreement”) with Lambert Private Equity, LLC, (the “Investor”). | accelera8k.htm |
| 2013-10-15 | 8-K | 2013-10-10 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 4, 2013, Accelera Innovations, Inc. a Delaware corporation (the “Company”), entered into a Standby Equity Purchase Agreement (the “Investment Agreement”) with Lambert Private Equity, LLC, a Delaware limited liability company (the “Investor”). | accelera8k_10112013.htm |
| 2012-12-24 | 8-K | 2012-12-18 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 The Board of Directors of Accelera Innovations, Inc. (the “Company”) approved of the engagement of Anton & Chia, LLP, Newport Beach, California as the Company’s new independent registered public accounting firm on December 17, 2012, and also Peter Messineo, CPA, Palm Harbor, Florida (“Messineo”) declined to stand for re-election from that role. | accel8kaudchg_12202012.htm |
| 2012-04-30 | 8-K | 2012-04-30 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | accelera8k_4302012.htm | |
| 2012-04-16 | 8-K/A | 2012-04-13 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 On April 13, 2012 Accelera Innovations Inc, (the “Company”) (formally known as Accelerated Acquisitions IV, Inc.) entered into an amended Licensing Agreement (“Agreement”) with Synergistic Holdings LLC, (Licensor) whereas the Company and Licensor agreed to amend the August 22, 2011 Licensing Agreement. | accelera8ka_4162012.htm |
| 2012-04-16 | 8-K | 2012-04-13 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 On April 13, 2012 Accelera Innovations Inc, (the “Company”) (formally known as Accelerated Acquisitions IV, Inc.) entered into an amended Licensing Agreement (“Agreement”) with Synergistic Holdings LLC, (Licensor) whereas the Company and Licensor agreed to amend the August 22, 2011 Licensing Agreement. | accelera8k_4132012.htm |
| 2012-04-13 | 8-K/A | 2011-08-22 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.06 Change in Shell Company Status | 1.01 On August 22, 2011, Accelerated Acquisitions IV (the “Company”) entered into a Licensing Agreement (“Licensing Agreement”) with Synergistic Holdings, LLC (“Licensor”) pursuant to which the Company was granted an exclusive, non-transferrable worldwide license for proprietary Internet-based, software (“CareNav”) that improves the functionality and performance of healthcare services by making clinical healthcare data available to healthcare consumers. 2.01 (f) of Form 8-K states that if the registrant was a shell company, like our company, the registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10. 5.06 Prior to the Company’s entry into the business of providing CareNav as a Software-as-a-Service (SaaS) that is intended to improve the functionality and performance of healthcare services by making clinical healthcare data available to healthcare consumers. | aaiv8ka_4132012.htm |
| 2011-08-29 | 8-K | 2011-08-22 | 1.01 Entry into a Material Definitive Agreement; 5.06 Change in Shell Company Status | 1.01 On August 22, 2011, Accelerated Acquisitions IV (the “Company”) entered into a Licensing Agreement (“Licensing Agreement”) with Synergistic Holdings, LLC (“Licensor”) pursuant to which the Company was granted an exclusive, non-transferrable worldwide license for proprietary Internet-based, software (“CareNav”) that improves the functionality and performance of healthcare services by making clinical healthcare data available to healthcare consumers. 5.06 Prior to the Company’s entry into the business of providing CareNav as a Software-as-a-Service (SaaS) that is intended to improve the functionality and performance of healthcare services by making clinical healthcare data available to healthcare consumers. | aaiv8k_8232011.htm |
| 2011-06-17 | 8-K | 2011-06-13 | 1.01 Entry into a Material Definitive Agreement; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On June 13, 2011, Synergistic Holdings, LLC (“Purchaser”) agreed to acquire 17,000,000 shares of the Company’s common stock par value $0.0001 for a price of $0.0001 per share. 5.01 See response to Item 1.01. 5.02 Resignation and Appointment of Director and Principal Officers. | aaiv8k_6172011.htm |